(+)-PD 128907 hydrochloride

Pricing Availability   Qty
Description: High affinity D3 agonist (D3 ≥ D2 > D4)
Chemical Name: (4aR,10bR)-3,4a,4,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride
Purity: ≥98% (HPLC)
Datasheet
Citations (9)
Reviews
Literature (3)

Biological Activity for (+)-PD 128907 hydrochloride

(+)-PD 128907 hydrochloride is a high affinity D3 dopamine receptor agonist (Ki = 2.3 nM). Displays 18 - 200-fold selectivity over other dopamine receptor subtypes.

Technical Data for (+)-PD 128907 hydrochloride

M. Wt 285.77
Formula C14H19NO3.HCl
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 300576-59-4
PubChem ID 11957668
InChI Key DCFXOTRONMKUJB-QMDUSEKHSA-N
Smiles CCCN3[C@@H]2COC1=CC=C(O)C=C1[C@H]2OCC3.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for (+)-PD 128907 hydrochloride

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
water 2.86 10

Preparing Stock Solutions for (+)-PD 128907 hydrochloride

The following data is based on the product molecular weight 285.77. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 34.99 mL 174.97 mL 349.93 mL
0.5 mM 7 mL 34.99 mL 69.99 mL
1 mM 3.5 mL 17.5 mL 34.99 mL
5 mM 0.7 mL 3.5 mL 7 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for (+)-PD 128907 hydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for (+)-PD 128907 hydrochloride

References are publications that support the biological activity of the product.

Bristow et al (1996) The behavioural and neurochemical profile of the putative DA D3 receptor agonist, (+)-PD 128907, in the rat. Neuropharmacology 35 285 PMID: 8783203

Pugsley et al (1995) Neurochemical and functional characterization of the preferentially selective DA D3 agonist PD 128907. J.Pharmacol.Exp.Ther. 275 1355 PMID: 8531103

Witkin et al (1998) Atypical antipsychotic-like effects of the DA D3 receptor agonist (+)-PD 128907. Eur.J.Pharmacol. 347 R1 PMID: 9741997


If you know of a relevant reference for (+)-PD 128907 hydrochloride, please let us know.

View Related Products by Target

View Related Products by Product Action

View all D3 Receptor Agonists

Keywords: (+)-PD 128907 hydrochloride, (+)-PD 128907 hydrochloride supplier, D3, agonists, D2, D4, Dopamine, Receptors, dopaminergic, (+)-PD128907, hydrochloride, PD128907, 1243, Tocris Bioscience

9 Citations for (+)-PD 128907 hydrochloride

Citations are publications that use Tocris products. Selected citations for (+)-PD 128907 hydrochloride include:

Chai et al (2017) Neural Circuit-Specialized Astrocytes: Transcriptomic, Proteomic, Morphological, and Functional Evidence. Neuron 95 531 PMID: 28712653

Marcellino et al (2008) Identification of DA D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. Neurosci Lett 283 26016 PMID: 18644790

Cote and Kuzhikandathil (2015) Chronic lev. treatment alters expression and function of DA D3 receptor in the MPTP/p mouse model of Parkinson's disease. J Neurosci 585 33 PMID: 25445374

Schulz et al (2012) First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors. Br J Pharmacol 167 1480 PMID: 22817643


Do you know of a great paper that uses (+)-PD 128907 hydrochloride from Tocris? Please let us know.

Reviews for (+)-PD 128907 hydrochloride

There are currently no reviews for this product. Be the first to review (+)-PD 128907 hydrochloride and earn rewards!

Have you used (+)-PD 128907 hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Dopamine Receptors Scientific Review

Dopamine Receptors Scientific Review

Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.